By physician referral or invitation only

A Double-blind, Randomized Long-Term Extension Study on Efficacy, Safety, Pharmacokinetics and Tolerability of TEV-48574 in Adults with IBD

The main purpose of this extension study is to see if 2 different doses of the study drug help to maintain symptom improvement in UC or CD.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Edward Barnes
Medicine-Gastroenterology

Study Type

Clinical or Medical
Interventional

Study Topics

Stomach, Digestion and Gut Health

IRB Number

23-0660

ClinicalTrials.gov

NCT05668013

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.